Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pauline Dürr
Observed names:
Dürr, Pauline,
P Dürr,
P. Dürr
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Comprehensive Cancer Center Erlangen
ORCID:
0000-0001-5772-4956
Observed ORCID:
0000-0001-5772-4956
OpenAlex ID:
A5015712395
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents
2021
·
Pauline Dürr
, Katja Schlichtig
, et al.
·
Journal of Clinical Oncology
·
127
New Oral Anti-Cancer Drugs and Medication Safety
2019
·
Katja Schlichtig
, Pauline Dürr
, et al.
·
Deutsches Ärzteblatt international
·
84
Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study
2021
·
Katja Schlichtig
, Pauline Dürr
, et al.
·
Clinical Pharmacology & Therapeutics
·
37
PDF
POLAR – „POLypharmazie, Arzneimittelwechselwirkungen und Risiken“ – wie können Daten aus der stationären Krankenversorgung zur Beurteilung beitragen?
2022
·
André Scherag
, Wahram Andrikyan
, et al.
·
Prävention und Gesundheitsförderung
·
17
PDF
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma
2021
·
Niklas Kehl
, Katja Schlichtig
, et al.
·
Cancers
·
16
PDF
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center
2023
·
Lisa Cuba
, Katja Schlichtig
, et al.
·
Healthcare
·
14
PDF
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial
2022
·
Pauline Dürr
, Florian Meier
, et al.
·
Journal of Clinical Medicine
·
11
PDF
Ökonomische Aspekte bei der Versorgung von Patient*innen mit neuen oralen Tumortherapeutika: Erkenntnisse aus der AMBORA-Studie
2022
·
Pauline Dürr
, Katja Schlichtig
, et al.
·
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen
·
11
PDF
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center
2024
·
Lisa Cuba
, Pauline Dürr
, et al.
·
JCO Oncology Practice
·
10
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial
2022
·
Katja Schlichtig
, Lisa Cuba
, et al.
·
Journal of Clinical Medicine
·
10
PDF
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy
2024
·
Lisa Cuba
, Pauline Dürr
, et al.
·
Clinical Pharmacology & Therapeutics
·
7
PDF
Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap
2022
·
Wahram Andrikyan
, Melanie I. Then
, et al.
·
British Journal of Clinical Pharmacology
·
7
PDF
Inconsistencies of absolute drug–drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs
2023
·
Laura Weisbach
, Anna K. Schuster
, et al.
·
British Journal of Clinical Pharmacology
·
5
Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data
2025
·
Michael I. Sponfeldner
, Pauline Dürr
, et al.
·
Clinical Pharmacology & Therapeutics
·
4
PDF
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics”
2024
·
Wahram Andrikyan
, Michael I. Sponfeldner
, et al.
·
British Journal of Clinical Pharmacology
·
3
NP-002 Medication safety in patients treated with oral antitumor agents: a prospective, randomised investigation to improve patient safety and well-being by intensified clinical pharmaceutical/pharmacological care
2020
·
P Dürr
, K Schlichtig
, et al.
·
European Journal of Hospital Pharmacy
·
3
PDF
Letters to the Editor
2025
·
Martin F. Fromm
, Michael I. Sponfeldner
, et al.
·
Deutsches Ärzteblatt international
·
2
PDF
Development of phenotype algorithms for the detection of adverse events in electronic health record data: a multicentre study
2026
·
Louisa Redeker
, Annette Haerdtlein
, et al.
·
BMJ Open
·
1
PDF
Auswirkungen auf die Arzneimitteltherapiesicherheit und Adhärenz in der Dermato‐Onkologie: Das AMBORA‐Therapiebegleitungskonzept für orale Antitumortherapeutika
2025
·
Lisa Cuba
, Frank Dörje
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Implications for medication safety and adherence in dermato‐oncology: The AMBORA care program for oral antitumor therapeutics
2025
·
Lisa Cuba
, Frank Dörje
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Show more works
View as search
Works count:
22
Citation count:
369
H-index:
10
I10-index:
10
Year
Topic
Type